Vertex Pharmaceuticals (Brazil) Price on May 17, 2024

VRTX34 Stock  BRL 690.81  5.70  0.82%   
If you're considering investing in Vertex Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vertex Pharmaceuticals stands at 690.81, as last reported on the 4th of December, with the highest price reaching 693.45 and the lowest price hitting 690.81 during the day. At this point, Vertex Pharmaceuticals is very steady. Vertex Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0721, which indicates the firm had a 0.0721% return per unit of risk over the last 3 months. We have found thirty technical indicators for Vertex Pharmaceuticals Incorporated, which you can use to evaluate the volatility of the company. Please validate Vertex Pharmaceuticals' Risk Adjusted Performance of 0.0079, coefficient of variation of 36122.68, and Semi Deviation of 1.74 to confirm if the risk estimate we provide is consistent with the expected return of 0.13%.
  
Vertex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0721

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskVRTX34High RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.75
  actual daily
15
85% of assets are more volatile

Expected Return

 0.13
  actual daily
2
98% of assets have higher returns

Risk-Adjusted Return

 0.07
  actual daily
5
95% of assets perform better
Based on monthly moving average Vertex Pharmaceuticals is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vertex Pharmaceuticals by adding it to a well-diversified portfolio.

Vertex Pharmaceuticals Valuation on May 17, 2024

It is possible to determine the worth of Vertex Pharmaceuticals on a given historical date. On May 17, 2024 Vertex was worth 568.86 at the beginning of the trading date compared to the closed value of 568.86. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vertex Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Vertex Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vertex Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vertex Pharmaceuticals' related companies.
 Open High Low Close Volume
  560.40    563.36    560.40    563.36    101.00  
05/17/2024
  568.86    568.86    568.86    568.86    2.00  
  568.80    571.14    568.80    568.86    4.00  
Backtest Vertex Pharmaceuticals  |  Vertex Pharmaceuticals History  |  Vertex Pharmaceuticals Valuation   PreviousNext  
Open Value
568.86
563.61
Downside
568.86
Closing Value
574.11
Upside

Vertex Pharmaceuticals Trading Date Momentum on May 17, 2024

On May 20 2024 Vertex Pharmaceuticals Incorporated was traded for  568.86  at the closing time. The highest price during the trading period was 571.14  and the lowest recorded bid was listed for  568.80 . There was no trading activity during the period 4.0. Lack of trading volume on May 20, 2024 did not result in any price rise and fall. The trading price change to the current price is 2.23% .

Vertex Pharmaceuticals Fundamentals Correlations and Trends

By evaluating Vertex Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vertex Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vertex financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Vertex Pharmaceuticals Stock history

Vertex Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vertex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vertex Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vertex Pharmaceuticals stock prices may prove useful in developing a viable investing in Vertex Pharmaceuticals
Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The company was founded in 1989 and is headquartered in Boston, Massachusetts. VERTEX PHARMDRN operates under Biotechnology classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 3400 people.

Vertex Pharmaceuticals Stock Technical Analysis

Vertex Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vertex Pharmaceuticals technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vertex Pharmaceuticals trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Vertex Pharmaceuticals Period Price Range

Low
December 4, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Vertex Pharmaceuticals Incorporated cannot be verified against its exchange. Please verify the symbol is currently traded on Sao Paulo Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Vertex Pharmaceuticals December 4, 2024 Market Strength

Market strength indicators help investors to evaluate how Vertex Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vertex Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Vertex Pharmaceuticals stock market strength indicators, traders can identify Vertex Pharmaceuticals Incorporated entry and exit signals to maximize returns

Vertex Pharmaceuticals Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Vertex Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Vertex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vertex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Vertex Stock analysis

When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data